These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 2126953
1. Immunohistopathologic studies in the development of psoriatic lesion influenced by gamma-interferon and the producing cells. Kaneko F, Suzuki M, Takiguchi Y, Itoh N, Minagawa T. J Dermatol Sci; 1990 Nov; 1(6):425-34. PubMed ID: 2126953 [Abstract] [Full Text] [Related]
2. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM. J Exp Med; 1986 Oct 01; 164(4):1013-28. PubMed ID: 2428913 [Abstract] [Full Text] [Related]
3. The effect of IFN-gamma on healthy and psoriatic keratinocytes in a skin equivalent model is influenced by the source of the keratinocytes and by their interactions with fibroblasts. Fransson J, Shen Q, Scheynius A, Hammar H. Arch Dermatol Res; 1996 Dec 01; 289(1):14-20. PubMed ID: 9017130 [Abstract] [Full Text] [Related]
4. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis. Huang BB, Bonish BK, Chaturvedi V, Qin JZ, Nickoloff BJ. J Invest Dermatol; 2001 Feb 01; 116(2):305-12. PubMed ID: 11180008 [Abstract] [Full Text] [Related]
11. UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions. Baadsgaard O, Tong P, Elder JT, Hansen ER, Ho V, Hammerberg C, Lange-Vejlsgaard G, Fox DA, Fisher G, Chan LS. J Invest Dermatol; 1990 Sep 01; 95(3):275-82. PubMed ID: 1974570 [Abstract] [Full Text] [Related]
12. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. Onuma S. J Dermatol; 1994 Apr 01; 21(4):223-32. PubMed ID: 7914525 [Abstract] [Full Text] [Related]
13. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. Bonish B, Jullien D, Dutronc Y, Huang BB, Modlin R, Spada FM, Porcelli SA, Nickoloff BJ. J Immunol; 2000 Oct 01; 165(7):4076-85. PubMed ID: 11034419 [Abstract] [Full Text] [Related]
14. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB. J Immunol; 2006 Feb 01; 176(3):1908-15. PubMed ID: 16424222 [Abstract] [Full Text] [Related]
15. Increased expression of CD208 (DC-LAMP) in epidermal keratinocytes of psoriatic lesions. Higaki M, Higaki Y, Kawashima M. J Dermatol; 2009 Mar 01; 36(3):144-9. PubMed ID: 19335688 [Abstract] [Full Text] [Related]
16. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. Szabo SK, Hammerberg C, Yoshida Y, Bata-Csorgo Z, Cooper KD. J Invest Dermatol; 1998 Dec 01; 111(6):1072-8. PubMed ID: 9856819 [Abstract] [Full Text] [Related]
19. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Paukkonen K, Naukkarinen A, Horsmanheimo M. Arch Dermatol Res; 1995 Dec 01; 287(2):165-70. PubMed ID: 7763088 [Abstract] [Full Text] [Related]